Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-22

Clinical Trial Update: Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC) [NA]

View source ↗

Summary

A clinical trial evaluating salivary cortisol as a diagnostic marker for infraclinical cortisol adenoma (ACIC) in obesity patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nantes University Hospital | Conditions: Obesity | NA | Status: TERMINATED